More Globe Newswire

View Older Stories View Newer Stories

Apr 28, 2025 07:28AM Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
Apr 28, 2025 07:17AM TikTok’s Favorite Foodie Kate Norkeliunas Teams Up with MGA’s Miniverse™ to Launch Make It Mini From Scratch™, The Collectible You Make Yourself
Apr 28, 2025 07:15AM ElevateBio Announces Transition of David Hallal to Executive Chairman of the Board of Directors
Apr 28, 2025 07:15AM NANO Nuclear Announces Full Dismissal of Nevada Lawsuit
Apr 28, 2025 07:12AM Share buy-back program
Apr 28, 2025 07:11AM Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu
Apr 28, 2025 07:06AM EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship
Apr 28, 2025 07:03AM Microchip Expands Connectivity, Storage and Compute Portfolios to Meet the Growing Demands of AI Data Center Applications
Apr 28, 2025 07:02AM Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
Apr 28, 2025 07:02AM Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025
Apr 28, 2025 07:01AM Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
Apr 28, 2025 07:01AM Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
Apr 28, 2025 07:00AM BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
Apr 28, 2025 07:00AM Biomed Valley Discoveries Announces First Patient Dosed in Phase 1/2 Combination Study of Ulixertinib with Ruxolitinib (Jakafi®) in Patients with Myelofibrosis
Apr 28, 2025 07:00AM Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award
Apr 28, 2025 07:00AM EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
Apr 28, 2025 07:00AM Kandi Technologies Reports 2024 Financial Results
Apr 28, 2025 07:00AM Nayax to Showcase End-to-End Payment Ecosystem at The NAMA Show, May 7-9 in Las Vegas
Apr 28, 2025 07:00AM Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
Apr 28, 2025 07:00AM Matador Technologies Inc. Announces Symbol Change and DTC Eligibility of its Common Shares
Apr 28, 2025 07:00AM Atana Expands Sales Team, Welcomes New Leaders to Drive Continued Growth
Apr 28, 2025 07:00AM Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025
Apr 28, 2025 07:00AM Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-posit
Apr 28, 2025 07:00AM Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
Apr 28, 2025 07:00AM Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting
Apr 28, 2025 07:00AM G2 Continues to Expand New Surface Gold Discovery and Provides Exploration Update
Apr 28, 2025 07:00AM Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Apr 28, 2025 07:00AM XORTX Announces Grant of European Patent
Apr 28, 2025 07:00AM Barrick Gold Corporation Plans to Change Name to BARRICK MINING CORPORATION
Apr 28, 2025 07:00AM Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
Apr 28, 2025 07:00AM Beamr to Participate in Upcoming Investor Conferences in May 2025
Apr 28, 2025 07:00AM ScottsMiracle-Gro CEO Reports Strong POS Unit Gains During CNBC Mad Money Appearance
Apr 28, 2025 07:00AM Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
Apr 28, 2025 07:00AM Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combine
Apr 28, 2025 07:00AM Globavend Receives Government Non-Dilutive Grant Funding Approval
Apr 28, 2025 07:00AM DecisionDx®-Melanoma Test Ordered More Than 200,000 Times for Patients Diagnosed with Cutaneous Melanoma
Apr 28, 2025 07:00AM Village Farms International Takes Top Honors at the 2025 Stevie® Awards
Apr 28, 2025 07:00AM Osisko Development Announces Optimized Feasibility Study for Permitted Cariboo Gold Project with C$943 Million After-Tax NPV5% and 22.1% IRR at US$2,400/oz Base Case Gold Price; at US$3,300/oz Spot Go
Apr 28, 2025 07:00AM Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients
Apr 28, 2025 07:00AM ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
Apr 28, 2025 07:00AM AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer
Apr 28, 2025 07:00AM Green Thumb to Open RISE Dispensary Ocala in Florida, its 104th Retail Location in the Nation, on April 29
Apr 28, 2025 07:00AM Benevity Appoints Industry’s First Chief Artificial Intelligence Officer
Apr 28, 2025 07:00AM Widmer Brothers Brewing Celebrates 40th Anniversary
Apr 28, 2025 07:00AM Prairie Operating Co. Begins Completion of the Opal Coalbank Pad, Acquired from Bayswater
Apr 28, 2025 07:00AM Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
Apr 28, 2025 07:00AM Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Apr 28, 2025 07:00AM CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Year-End 2024, Q1-2025, No Effects from Tariffs
Apr 28, 2025 07:00AM Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025
Apr 28, 2025 07:00AM Aktsiaselts Infortar Investor Webinar introducing the results of the Q1 2025
View Newer Stories View Older Stories